378 related articles for article (PubMed ID: 9513825)
1. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
5. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Haber M
Am J Gastroenterol; 1996 Sep; 91(9):1758-65. PubMed ID: 8792694
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
Chelvam P; Wong EC
J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
[TBL] [Abstract][Full Text] [Related]
7. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
Pace F; Sangaletti O; Bianchi Porro G
Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
[TBL] [Abstract][Full Text] [Related]
8. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
Cappelli J; Morobe J; Van Laethem A; Musin L
Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
10. Giant gastric ulcer: its natural history and outcome in the H2RA era.
Raju GS; Bardhan KD; Royston C; Beresford J
Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
[TBL] [Abstract][Full Text] [Related]
11. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
[TBL] [Abstract][Full Text] [Related]
13. [H2-blocker refractory ulcers: what can be done?].
Dammann HG
Z Gastroenterol; 1992 Apr; 30(4):268-71. PubMed ID: 1351328
[TBL] [Abstract][Full Text] [Related]
14. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
15. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
Koop H; Katschinski M; Arnold R
Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
17. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
Ladas SD; Tassios PS; Raptis SA
Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
[TBL] [Abstract][Full Text] [Related]
18. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
19. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
